# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001759425-26-000010
Filing Date
2026-02-25
Accepted
2026-02-25 16:03:49
Documents
14
Period of Report
2026-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | mirm-20260225.htm iXBRL | 8-K | 27178
2 | EX-99.1 | mirm-20260225xexx991.htm | EX-99.1 | 124471
6 |  | image.jpg | GRAPHIC | 1005151
| Complete submission text file | 0001759425-26-000010.txt |  | 1589539

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mirm-20260225.xsd | EX-101.SCH | 1782
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mirm-20260225_lab.xml | EX-101.LAB | 21885
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mirm-20260225_pre.xml | EX-101.PRE | 12508
16 | EXTRACTED XBRL INSTANCE DOCUMENT | mirm-20260225_htm.xml | XML | 2875

Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 26678377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)